EKSO:NASDAQ
엑소 바이오닉스
US$11.21
arrow_downward
-1.41%(-0.16) 1D
4월 28일, 오후 4시 0분 0초 GMT-4 · USD
search
모든 종목 코드
1D
5D
1M
6M
YTD
1Y
5Y
최대
| 종목 코드 | 가격 | 변동 | 변동률(%) |
|---|
insights_autoEKSO의 주요 통계 생성 중...
시가
US$11.50
고가
US$11.64
저가
US$10.85
시가총액
3994.55만
평균 거래량
7.31만
거래량
4.60만
52주 최고가
US$13.50
52주 최저가
US$2.75
EPS
-US$4.91
베타
0.78
유통 주식수
356.30만
직원 수
50
뉴스 기사
웹 소스 기반
프로필
Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis or spinal cord injury. They enable individuals with any amount of lower extremity weakness, including those who are paralyzed, to stand up and walk.
Ekso Bionics currently focuses in the health and industrial sectors.
The company's first commercially available health product was called EksoGT. Ekso Bionics is the original developer of HULC, now under military development by Lockheed Martin, and the current developers of EksoNR, which allows patients who are relearning to walk the ability to stand and take steps. In December 2022, Ekso Bionics acquired the Human Motion & Control business unit from Parker Hannifin which includes the Indego product line. This acquisition allowed Ekso Bionics to begin selling exoskeletons to those who have an SCI and want a personal exoskeleton to walk at home and in their community. Wikipedia
엑소 바이오닉스에 관한 정보